Dr Eric Tang Ho-man obtained his PhD from the Department of Family Medicine and Primary Care at the University of Hong Kong. His research interests include development and validation of artificial intellengce model for natural language processing tasks in clinical oncology, evaluation of effectiveness and cost-effectiveness of healthcare interventions on chronic diseases, and evaluation of health-related quality of life.

1. Fung MMH, Tang EHM, Wu T et al. Developing a named entity framework for thyroid cancer staging and risk level classification using large language models. npj Digit. Med. 2025;8(1):134. (co-first author)
2. Tang EHM, Mak IL, Tse ETY et al. Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study. Diabetes Care 2022;45(12):2871-2882.
3. Lee CH, Mak LY, Tang EHM et al. SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong. Hepatology 2023;78(5):1569-1580. (co-first author)
4. Lui DTW, Tang EHM, Wu T et al. Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong. Cardiovascular Diabetology 2023;22:40. (co-first author)
5. Lui DTW, Tang EHM, Au ICH et al. Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants. Diabetes Care 2022;45(11):2620–2627.
6. Wong CKH, Lau KTK, Tang EHM et al. Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study. Cardiovascular Diabetology 2022;21:92. (co-first author)
7. Bedford LE, Tang EHM, Dong W et al. Who reports insufficient and disturbed sleep? Results from a representative population-based health survey in Hong Kong. BMJ Open 2022;12:e058169. (co-first author)
8. Tang EHM, Wong CKH, Lau KTK et al. Cardio-renal outcomes and the direct medical cost of type 2 diabetes patients treated with sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based cohort study. Diabetes Research and Clinical Practice 2021;180:109071.
9. Tang EHM, Bedford LE, Yu EYT. Unintentional Injury Burden in Hong Kong: Results from a Representative Population-Based Survey. Int. J. Environ. Res. Public Health 2021;18(16):8826.
10. Tang EHM, Wong CKH, Bedford LE et al. Trend in health-related quality of life and health utility and their decrements due to non-communicable diseases and risk factors: analysis of four population-based surveys between 1998 and 2015. Quality of Life Research 2020;29:2921–2934.